Hosted by the ALS Association of Argentina, we are pleased to share a new update on the ATLAS trial, designed for healthy carriers of the SOD-1 gene, presented by Dr. Michael Benatar, Professor of Neurology and Public Health Sciences at the University of Miami, Chief of the Neuromuscular Division, and Executive Director of the ALS Center.

Watch the webinar here!